A dual-action HIV antibody–drug conjugate forces Env to open, then blocks it, boosting virus neutralization up to tenfold in ...

For people living with human immunodeficiency virus (HIV), life-saving antiretroviral therapy keeps their HIV-infected immune ...

Draft amendments to the Drugs Rules would remove duplicate viral tests on finished plasma-derived medicines once source ...

HIV-seq identifies key differences in HIV-infected cells before and after starting antiretroviral therapy to support treatment research.

While the rate of HIV in Kampala, Uganda, is more than double the national average, a recent survey of displaced youths in the city found that only ...

This case has exposed systemic weaknesses in Uganda’s medical laboratory sector, raising concerns about test accuracy, competence, and ethics. Medical laboratory tests are central to diagnosing ...

For people living with human immunodeficiency virus (HIV), life-saving antiretroviral therapy keeps their HIV-infected immune ...

Scientists at Gladstone Institutes, in collaboration with a team at the San Francisco Veterans Affairs Medical Center, have ...

The World Health Organization (WHO) is issuing, for the first time, recommendations on new near-point-of-care (NPOC) ...

The approach relies on a specially engineered scaffold that links three naturally occurring cytokines known to promote immune memory.

Katherine Stueland is the CEO of GeneDx, who led the company from a financially challenged phase to profitability in just 3 years. Currently, she leads efforts ...